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The human placenta manufactures antibodies that may shield the fetus from immune damage, according to new findings. These placental IgG antibodies bind to other antibodies and immune cells.
Maternal IgG antibodies are known to cross the placenta to fortify the immune system of the fetus. Researchers have proposed that the placenta can filter out detrimental antibodies directed to paternal antigens, but evidence for such a filter has been scant. The new data, published in Human Reproduction and Biology of Reproduction, provides a glimpse of a mechanism.
Jiang Gu and his colleagues were intrigued by previous observations that IgG antibodies are present in the placenta. In Human Reproduction, the researchers show that these antibodies are produced endogenously [1] . For instance, human epithelial and trophoblast cells contained transcripts encoding IgG molecules; cultured trophoblast cells produced such antibodies; and mice lacking B cells had IgG antibodies in placental tissue. These findings echo reports of IgG antibody production in non-immune cells such as neurons, cancer cells, and spermatogenic cells. The researchers went on to show that about 30 percent of these placentally produced antibodies came in an unusual form-they were glycosylated on one of their Fab arms. These glycosylated antibodies bound nonspecifically to other IgG antibodies, as well as to monocytes and neutrophils.
Glycoslated IgG antibodies have been called ''blocking antibodies'' because they do not prompt immune responses such as phagocytosis. Similarly, the researchers speculate that the glycosylated IgG antibodies neutralize the antibodies to which they bind.
The findings suggest that glycoslated IgG may be one way the fetus is shielded from immune attack by the mother. Future studies should provide answers to questions such as how nonthreatening, useful maternal antibodies might make it through this defense system, and how this system might interact with other immune-shielding mechanisms.
In a follow-up study in Biology of Reproduction, Gu and his colleagues provide evidence that incoming IgG antibodies are processed in two distinct compartments in syncytiotrophoblasts [2] . One compartment, the endosomal compartment, contains the IgG receptor FcRN and may be involved in transporting IgG to the fetus. A second compartment is a newly described structure containing clustered complexes of immune molecules-the researchers speculate that this compartment serves as a ''sink'' for detrimental antibodies directed against paternal antigens.
